Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Hironobu Minami et al.|Journal of Clinical Oncology|2019Cited by 168
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yuichi Takiguchi et al.|JAMA Oncology|2020Cited by 119
Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutationRyota Kurimoto, Yuichi Takiguchi|International Journal of Oncology|2016Cited by 70
Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinomaRyota Kurimoto, Yuichi Takiguchi|Oncology Letters|2017Cited by 39
Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancersMengmeng Fan, Yuichi Takiguchi|Oncology Reports|2021Cited by 12